MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)
Clinical trial NCT00372060 · COMPLETED
Trial details
- NCT number
- NCT00372060
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-21
- Primary completion
- 2008-02-05
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.